Reports >
Life Sciences
>
Biological Safety Testing Market Report
Biological Safety Testing Market Report
Published Date: 22 April 2026 | Report Code: biological-safety-testing
Biological Safety Testing Market Size, Share, Industry Trends and Forecast to 2033
This report provides a detailed analysis of the Biological Safety Testing market, including insights on market size, regional performance, industry trends, and future forecasts for the period 2023 to 2033.
Key Takeaways
- Market baseline: $5.60 Billion in 2023, expanding to $11.01 Billion by 2033 with a projected 6.8% CAGR.
- North America is both the largest and the fastest-growing region, increasing from $1.96 Billion to $3.86 Billion.
- Europe and Asia Pacific show notable growth: Europe from $1.44 Billion to $2.82 Billion; Asia Pacific from $1.2 Billion to $2.36 Billion.
- Fundamental growth drivers include stricter safety regulations, advances in biotechnology, and rising R&D spending in life-sciences.
- Key service providers shaping the market include SGS S.A., Charles River Laboratories, Eurofins Scientific, and LGC Group.
Biological Safety Testing Market Report — Executive Summary
This report presents a market-focused assessment of biological safety testing from 2023 to 2033, with the global market at $5.60 Billion in 2023 and projected to reach $11.01 Billion by 2033 at a 6.8% CAGR. Expansion is underpinned by tighter regulatory frameworks, heightened emphasis on patient safety, and technological improvements that shorten testing cycles. The landscape spans microbial, biocompatibility, and viral safety services across pharmaceutical, medical device, and biotechnology sectors. Regional trajectories vary, led by North America as the dominant and fastest-growing market. The study profiles major players including SGS S.A., Charles River Laboratories, Eurofins Scientific, and LGC Group, and maps segmentation, demand drivers, and adoption trends for stakeholders and decision makers.
Key Growth Drivers
- Heightened regulatory scrutiny requiring comprehensive microbial, biocompatibility, and viral safety assessments.
- Advancements in biotechnology and testing methodologies that increase throughput and detection accuracy.
- Rising investment in pharmaceutical and medical device R&D that expands demand for third‑party testing services.
- Increased awareness of patient safety and contamination risks following infectious disease outbreaks.
- Adoption of automated and digital testing solutions that improve efficiency and reduce turnaround times.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $5.60 Billion |
| CAGR (2023-2033) | 6.8% |
| 2033 Market Size | $11.01 Billion |
| Top Companies | SGS S.A., Charles River Laboratories, Eurofins Scientific, LGC Group |
| Last Modified Date | 22 April 2026 |
Biological Safety Testing Market Overview
Customize Biological Safety Testing Market Report market research report
- ✔ Get in-depth analysis of Biological Safety Testing market size, growth, and forecasts.
- ✔ Understand Biological Safety Testing's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Biological Safety Testing
What is the Market Size & CAGR of Biological Safety Testing Market Report market in 2023?
Biological Safety Testing Industry Analysis
Biological Safety Testing Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Biological Safety Testing Market Report Market Analysis Report by Region
Europe Biological Safety Testing Market Report:
Europe is set to grow from $1.44 Billion in 2023 to $2.82 Billion in 2033. Regional expansion is driven by regulatory harmonization, increasing biotech activity, and demand for standardized testing protocols across pharmaceutical and medical device manufacturers.Asia Pacific Biological Safety Testing Market Report:
Asia Pacific increases from $1.2 Billion in 2023 to $2.36 Billion in 2033. Growth stems from rising healthcare investments, expanding biotechnology sectors, and growing requirements for safety testing as markets internationalize and regulatory expectations evolve.North America Biological Safety Testing Market Report:
North America is the largest and fastest-growing region, expanding from $1.96 Billion in 2023 to $3.86 Billion in 2033. This growth reflects strong life‑sciences R&D investment, rigorous regulatory oversight, and rapid uptake of advanced testing platforms that improve safety verification and compliance.South America Biological Safety Testing Market Report:
Middle East & Africa Biological Safety Testing Market Report:
Middle East and Africa rise from $0.6 Billion in 2023 to $1.19 Billion in 2033. Development is linked to increasing healthcare investments, growing regulatory focus, and adoption of testing services to support local pharmaceutical and medical device markets.Tell us your focus area and get a customized research report.
Research Methodology
Biological Safety Testing Market Analysis By Type
Microbial Testing accounted for a significant market size of approximately $3.69 billion in 2023, projected to reach $7.26 billion by 2033. This segment represents 65.97% market share, driven by the high demand for microbial control in pharmaceuticals. Biocompatibility Testing, currently valued at $1.60 billion, is expected to grow to $3.14 billion (28.57% share). Viral Safety Testing, while smaller, remains essential, with insights projecting growth from $0.31 billion to $0.60 billion.
Biological Safety Testing Market Analysis By Industry
The segment includes Pharmaceuticals, which leads with a market size of $3.69 billion expected to rise to $7.26 billion by 2033, and is indicative of the industry's reliance on safety testing protocols due to regulatory requirements. Medical Devices follow with a market size of $1.60 billion growing to $3.14 billion, representing vital compliance needs, while Biotechnology, currently at $0.31 billion, is also expected to scale up similarly, reaching $0.60 billion by 2033.
Biological Safety Testing Market Analysis By Region
The regional analysis emphasizes North America's dominance, forecasted to retain its leading position through 2033 due to strong investments in healthcare and safety measures. Europe and Asia Pacific follow closely behind, leveraging regulatory frameworks to bolster their growth perspectives. South America and Middle East & Africa provide emerging opportunities aligning with increased healthcare demands and safety assurances.
Biological Safety Testing Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Biological Safety Testing Industry
SGS S.A.:
SGS S.A. is a global leader in inspection, verification, testing, and certification, providing biological safety testing services that cater to various industries. Their commitment to quality and innovation makes them a trusted partner for product safety.Charles River Laboratories:
As a renowned entity in preclinical and clinical laboratory services, Charles River Laboratories offers extensive biological safety testing solutions crucial for the development of new pharmaceuticals and medical devices.Eurofins Scientific:
Eurofins is a global group of laboratories that provides innovative biosafety testing services, serving the pharmaceutical and biopharmaceutical sectors, with a strong emphasis on high-quality processes and customer satisfaction.LGC Group:
LGC is known for its comprehensive biological safety testing services and high standards of quality and accuracy, ensuring products meet regulatory requirements efficiently.We're grateful to work with incredible clients.
FAQs
What is the market size of the Biological Safety Testing Market Report in 2023?
The market size was $5.60 Billion in 2023 according to the report data, serving as the baseline for projections and regional breakdowns through the 2023 to 2033 forecast period.
How big will the market be in 2033?
By 2033 the market is projected to reach $11.01 Billion, reflecting cumulative growth driven by regulatory requirements, technological advances, and expanded testing demand in life-sciences sectors.
What is CAGR of the Biological Safety Testing Market Report?
The forecast period 2023 to 2033 carries an expected compound annual growth rate of 6.8%, indicating steady expansion across services and regions over the decade.
Why is North America the largest region?
North America leads due to strong R&D investment, robust regulatory frameworks, and widespread adoption of advanced testing protocols, supporting high demand and market concentration in the region.
Which companies lead the Biological Safety Testing market?
Leading providers identified include SGS S.A., Charles River Laboratories, Eurofins Scientific, and LGC Group, which offer a range of testing services and sector-specific expertise.
Who are the primary industries driving demand for safety testing?
Pharmaceuticals, medical devices, and biotechnology sectors are primary demand drivers, requiring microbial, biocompatibility, and viral safety testing as part of product development and regulatory compliance.
What are the main testing segments covered in the market?
Key service segments include microbial testing, biocompatibility testing, and viral safety testing, each addressing distinct safety needs across healthcare product development and manufacturing.
How big is Europe in 2023 and 2033?
Europe is reported at $1.44 Billion in 2023 and is expected to grow to $2.82 Billion by 2033, reflecting regulatory harmonization and growing biotech activity in the region.